BioTime Announces the Issuance of 27 New Patents Protecting Stem Cell-Based Product Development

BioTime, Inc. (NYSE MKT:BTX) today announced that 27 new patents have issued during the first half of 2015 that are owned or licensed to BioTime or its subsidiaries. These new patents add to the portfolio of over 700 issued and pending patents and patent …

[Read the full article here]

Comments are closed.